Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

July 22, 2024 — The researchers report the ability of protein 'signatures' to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease ...

Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

24 Although the benefit of CAR T-cell therapy for multiple myeloma continues to outweigh the risk, vigilant monitoring for T-cell lymphoma should be implemented. Supported by Johnson & Johnson and ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where ...

Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS.Jason Johnson was diagnosed with myeloma - a form of bone cancer - in 2014 ...

as well as in combination with Sarclisa in myeloma, lymphoma and solid tumours. A phase 3 win suggests Takeda's $300m wager on Protagonist's rusfertide for rare blood cancer polycythaemia vera (PV ...

Planning Activities Are Ongoing for Next Phase of Cemsidomide Clinical Development in Multiple Myeloma and Non-Hodgkin’s Lymphoma; Trials ...